IPO registrations (S-1, F-1) · Registrants
Rocket One Inc.
- SEC CIK
- 1711786 · filings on EDGAR ↗
- Name on the registration
- Hoth Therapeutics, Inc.
- Former names
- Hoth Therapeutics, Inc. (2017–2026)
- Registration
- Form S-1, first filed 2018-10-10, last 2024-04-11; 5 initial registrations, 10 amendments
- Outcome
- Final prospectus filed 2019-02-15; declared effective 2019-02-14
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- NV
- Business address
- 720 MONROE STREET, SUITE E514, Hoboken, NJ 07030
- EIN
- 82-1553794
- Ticker
- RKTO (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Rocket One Inc. on the corporate pages
Offering terms
- Proposed price range
- $5.50–$6.50 per share (S-1/A filed 2019-02-11)
- Final price
- $5.00 per share, below the range (424B4 filed 2019-02-15, an initial public offering)
- Shares sold
- 1,250,000
- Gross proceeds
- $6,250,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol HOTH
- Lead underwriters
- Laidlaw & Company (1,250,000 shares)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: HOTH THERAPEUTICS, INC. EXACT (EIN (EXACT))
- Form D issuer: Hoth Therapeutics, Inc. EXACT (CIK (EXACT))
- SEC filer: Hoth Therapeutics, Inc. EXACT (CIK (EXACT))
Filings 27
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2018-10-10 | S-1 | S-1 (registration) | Hoth Therapeutics, Inc. | 0001615774-18-010669 ↗ |
| 2018-12-14 | S-1/A | S-1/A (amendment) | Hoth Therapeutics, Inc. | 0001615774-18-014482 ↗ |
| 2019-01-11 | S-1/A | S-1/A (amendment) | Hoth Therapeutics, Inc. | 0001615774-19-000531 ↗ |
| 2019-02-01 | S-1/A | S-1/A (amendment) | Hoth Therapeutics, Inc. | 0001615774-19-001684 ↗ |
| 2019-02-04 | S-1/A | S-1/A (amendment) | Hoth Therapeutics, Inc. | 0001615774-19-001852 ↗ |
| 2019-02-05 | S-1/A | S-1/A (amendment) | Hoth Therapeutics, Inc. | 0001615774-19-001957 ↗ |
| 2019-02-06 | S-1/A | S-1/A (amendment) | Hoth Therapeutics, Inc. | 0001615774-19-002001 ↗ |
| 2019-02-11 | S-1/A | S-1/A (amendment) | Hoth Therapeutics, Inc. | 0001615774-19-002253 ↗ |
| 2019-02-14 | EFFECT | EFFECT (declared effective) | Hoth Therapeutics, Inc. | 9999999995-19-000250 ↗ |
| 2019-02-15 | 424B4 | 424B4 (final prospectus) | Hoth Therapeutics, Inc. | 0001615774-19-002658 ↗ |
| 2019-08-30 | S-1 | S-1 (registration) | Hoth Therapeutics, Inc. | 0001213900-19-017016 ↗ |
| 2019-09-11 | S-1/A | S-1/A (amendment) | Hoth Therapeutics, Inc. | 0001213900-19-017735 ↗ |
| 2019-09-13 | EFFECT | EFFECT (declared effective) | Hoth Therapeutics, Inc. | 9999999995-19-002094 ↗ |
| 2019-09-26 | S-1 | S-1 (registration) | Hoth Therapeutics, Inc. | 0001213900-19-019010 ↗ |
| 2019-10-23 | S-1/A | S-1/A (amendment) | Hoth Therapeutics, Inc. | 0001213900-19-020936 ↗ |
| 2019-10-25 | EFFECT | EFFECT (declared effective) | Hoth Therapeutics, Inc. | 9999999995-19-002397 ↗ |
| 2020-03-11 | EFFECT | EFFECT (declared effective) | Hoth Therapeutics, Inc. | 9999999995-20-000555 ↗ |
| 2020-04-03 | S-1 | S-1 (registration) | Hoth Therapeutics, Inc. | 0001213900-20-008546 ↗ |
| 2020-05-05 | S-1/A | S-1/A (amendment) | Hoth Therapeutics, Inc. | 0001213900-20-011025 ↗ |
| 2020-05-06 | EFFECT | EFFECT (declared effective) | Hoth Therapeutics, Inc. | 9999999995-20-001061 ↗ |
| 2021-01-15 | EFFECT | EFFECT (declared effective) | Hoth Therapeutics, Inc. | 9999999995-21-000177 ↗ |
| 2021-04-05 | EFFECT | EFFECT (declared effective) | Hoth Therapeutics, Inc. | 9999999995-21-001284 ↗ |
| 2023-01-25 | EFFECT | EFFECT (declared effective) | Hoth Therapeutics, Inc. | 9999999995-23-000183 ↗ |
| 2023-06-16 | EFFECT | EFFECT (declared effective) | Hoth Therapeutics, Inc. | 9999999995-23-001783 ↗ |
| 2024-04-11 | S-1 | S-1 (registration) | Hoth Therapeutics, Inc. | 0001213900-24-032207 ↗ |
| 2024-04-19 | EFFECT | EFFECT (declared effective) | Hoth Therapeutics, Inc. | 9999999995-24-001054 ↗ |
| 2025-12-04 | EFFECT | EFFECT (declared effective) | Hoth Therapeutics, Inc. | 9999999995-25-003543 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2019-02-11 | S-1/A | registration statement | $5.50–$6.50 | 1,250,000 | - | Nasdaq HOTH | 2 | primary document; range, shares headline, underwriting table 1, cover names 1 | document ↗ | |
| 2019-02-15 | 424B4 | final prospectus | $5.00 | 1,250,000 | $6,250,000 | Nasdaq HOTH | 1 | primary document; price sentence, shares headline, proceeds computed, underwriting table 1, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Hayes Anthony | Director; Other; TenPercentOwner | 5 | 2019–2021 | ||
| Knie Robb | Director,Officer | CEO and President | 16 | 2019–2026 | |
| MATS VADIM | Director | 4 | 2019–2021 | ||
| RICE KENNETH L JR | Director | 3 | 2019–2020 | ||
| Sarnoff David | Director | 9 | 2019–2026 | ||
| AHERN JAMES P. | TenPercentOwner | 1 | 2019 | ||
| EITNER MATTHEW D. | TenPercentOwner | 2 | 2019 | ||
| Poor Kevin Jess | TenPercentOwner | 2 | 2019 | ||
| Briones David S. | Officer | Chief Financial Officer | 2 | 2019 | |
| AIkido Pharma Inc. | TenPercentOwner | 2 | 2020–2021 | ||
| Springer Graig | Director | 9 | 2020–2025 | ||
| Linsley Wayne | Director | 9 | 2020–2026 | ||
| Johns Stefanie | Officer | Chief Scientific Officer | 3 | 2020–2022 | |
| Pavell Jeff | Director | 6 | 2022–2026 | ||
| Camarra Christopher Michael | Director | 2 | 2025–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2023-01-04 | Hoth Therapeutics, Inc. | Biotechnology | $10,000,000 | $10,000,000 | 1 | 1 |
| 2021-03-16 | Hoth Therapeutics, Inc. | Pharmaceuticals | $15,000,000 | $15,000,000 | 13 | 1 |
| 2021-01-08 | Hoth Therapeutics, Inc. | Pharmaceuticals | $5,000,000 | $5,000,000 | 3 | 1 |
| 2019-08-21 | Hoth Therapeutics, Inc. | Pharmaceuticals | $5,000,000 | $2,037,120 | 53 | 1 |
| 2017-11-07 | Hoth Therapeutics, Inc. | Pharmaceuticals | $5,000,000 | $1,000,000 | 5 | 1 |
| 2017-07-14 | Hoth Therapeutics, Inc. | Pharmaceuticals | $675,000 | $675,000 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | HOTH THERAPEUTICS, INC. | NY | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Form D issuer | Hoth Therapeutics, Inc. | NY | Form D private offerings | CIK (EXACT) |
| SEC filer | Rocket One Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Form 5500 plan sponsor | HOTH THERAPEUTICS, INC. | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, NJ first:
- KOS PHARMACEUTICALS INC NJ
- NOVADEL PHARMA INC NJ
- ELITE PHARMACEUTICALS INC /NV/ NJ
- MEMORY PHARMACEUTICALS CORP NJ
- PHIBRO ANIMAL HEALTH CORP NJ
- PTC THERAPEUTICS, INC. NJ
- ADVANCED NUTRACEUTICALS INC NJ
- Ayala Pharmaceuticals, Inc. NJ
- INSMED Inc NJ
- Sonnet BioTherapeutics Holdings, Inc. NJ
In other datasets, the same topic (Health) in NJ:
- Nonprofit: 1ST CEREBRAL PALSY OF NEW JERSEY INC (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health